Applications for new human medicines under evaluation: August 2025

Vaccine Monitoring Platform

Vaccine Monitoring Platform: List of EMA-funded studies

Workshop on a tailored clinical approach in biosimilar development, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 September 2025, 09:00 (CEST) to 22 September 2025, 15:00 (CEST)

Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)

Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars

Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP

Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of authorisation: 18/08/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Enurev Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 11, Status: Authorised